ReviewInfectious disease reports2023

Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence.

Ioannis Karniadakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.